Talking Ketamine Podcast
@talkingketamine.com did:plc:5odisx65j4fwkbyhtdmv55ct
A weekly podcast that focuses on recent Ketamine research. Subscribe on your favorite platform: https://pod.link/1784108044
Bluesky’a katılma tarihi:
- Takipçi
- 43
- Takip edilen
- 59
- Post
- 63
- Sıralamaya girdiği gün
- 0
Özet
Talking Ketamine Podcast (@talkingketamine.com), 5 Aralık 2025 tarihinde katılan bir Bluesky kullanıcısı. 43 takipçisi var, 59 hesabı takip ediyor ve 63 post paylaştı.
Sıralama geçmişi
Bu hesabın postlarının Debya günlük listesine girdiği en iyi günler.
Bu hesap henüz günlük sıralamaya girmedi.
Son beğendiği postlar
Bluesky ağındaki herkese açık beğeniler.
every single one of you who make jokes about ketamine are adding to the stigma surrounding my & many others mental health. mental health is so important, please stop using my prescribed medication as a way to make fun of people, idgf who you’re making fun of, stop.
Postu göster#ScienceAlert: #ANES26 research suggests the benefits of ketamine may extend beyond anesthesia/pain relief to mothers’ mental health post-delivery. The study found ketamine during or after C-section was linked to fewer early postpartum depressive symptoms: www.asahq.org/about-asa/ne...
Postu gösterKetamine completely changed the conversation around antidepressant mechanisms. Rapid effects. Glutamatergic signaling. Synaptic plasticity. Circuit-level models. And yet we still have important unanswered questions about durability, patient selection, mechanisms, and long-term treatment strategies
Postu gösterOctober 15, 2026: NRx said the FDA asks only minor labeling changes for its preservative-free ketamine; GDUFA goal date November 10. $NRXP https://www.merlintrader.com/nrx-pharmaceuticals-stock-hub/
Postu gösterKetamine, MDMA and psilocybin may be the golden bullets for PTSD, addiction and depression.
Postu göster
Blokladığı hesaplar
Bluesky’da bloklar herkese açık kayıtlardır.
